316 related articles for article (PubMed ID: 23832526)
1. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
3. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
4. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
5. Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?
Heiland S; Wick W; Bendszus M
J Clin Oncol; 2010 Oct; 28(29):e591; author reply e592. PubMed ID: 20837945
[No Abstract] [Full Text] [Related]
6. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neovascularization patterns in an orthotopic rat glioma model with dynamic contrast-enhanced MRI.
Xuesong D; Wei X; Heng L; Xiao C; Shunan W; Yu G; Weiguo Z
Acta Radiol; 2017 Sep; 58(9):1138-1146. PubMed ID: 27956462
[TBL] [Abstract][Full Text] [Related]
8. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
9. Classic models for dynamic contrast-enhanced MRI.
Sourbron SP; Buckley DL
NMR Biomed; 2013 Aug; 26(8):1004-27. PubMed ID: 23674304
[TBL] [Abstract][Full Text] [Related]
10. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
[TBL] [Abstract][Full Text] [Related]
11. Dynamic susceptibility contrast MRI of gliomas.
Aronen HJ; Perkiö J
Neuroimaging Clin N Am; 2002 Nov; 12(4):501-23. PubMed ID: 12687908
[TBL] [Abstract][Full Text] [Related]
12. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
13. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
[TBL] [Abstract][Full Text] [Related]
14. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
15. Glioma Angiogenesis and Perfusion Imaging: Understanding the Relationship between Tumor Blood Volume and Leakiness with Increasing Glioma Grade.
Jain R; Griffith B; Alotaibi F; Zagzag D; Fine H; Golfinos J; Schultz L
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2030-5. PubMed ID: 26206809
[TBL] [Abstract][Full Text] [Related]
16. T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.
Rochetams BB; Marechal B; Cottier JP; Gaillot K; Sembely-Taveau C; Sirinelli D; Morel B
Neuroradiol J; 2017 Oct; 30(5):429-436. PubMed ID: 28556691
[TBL] [Abstract][Full Text] [Related]
17. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?
Bisdas S; Braun C; Skardelly M; Schittenhelm J; Teo TH; Thng CH; Klose U; Koh TS
NMR Biomed; 2014 Oct; 27(10):1184-91. PubMed ID: 25088433
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI and CT provide comparable measurement of blood-brain barrier permeability in a rodent stroke model.
Merali Z; Wong T; Leung J; Gao MM; Mikulis D; Kassner A
Magn Reson Imaging; 2015 Oct; 33(8):1007-12. PubMed ID: 26117703
[TBL] [Abstract][Full Text] [Related]
19. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI.
Cuenod CA; Balvay D
Diagn Interv Imaging; 2013 Dec; 94(12):1187-204. PubMed ID: 24211260
[TBL] [Abstract][Full Text] [Related]
20. [Role of perfusion, vascular permeability and anatomic MR imaging in radiation therapy for gliomas].
Dhermain F
Bull Cancer; 2010 Jul; 97(7):753-8. PubMed ID: 20610378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
